AR046893A1 - Bencimidazoles triciclicos - Google Patents
Bencimidazoles triciclicosInfo
- Publication number
- AR046893A1 AR046893A1 ARP040104662A ARP040104662A AR046893A1 AR 046893 A1 AR046893 A1 AR 046893A1 AR P040104662 A ARP040104662 A AR P040104662A AR P040104662 A ARP040104662 A AR P040104662A AR 046893 A1 AR046893 A1 AR 046893A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- alkoxy
- fluoroalkyl
- cycloalkyl
- hydrogen
- Prior art date
Links
- 125000003709 fluoroalkyl group Chemical group 0.000 abstract 8
- 150000002431 hydrogen Chemical class 0.000 abstract 8
- 229910052739 hydrogen Inorganic materials 0.000 abstract 8
- 239000001257 hydrogen Substances 0.000 abstract 8
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 7
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 abstract 6
- 125000000217 alkyl group Chemical group 0.000 abstract 6
- 125000002853 C1-C4 hydroxyalkyl group Chemical group 0.000 abstract 4
- 125000004428 fluoroalkoxy group Chemical group 0.000 abstract 4
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 150000002367 halogens Chemical class 0.000 abstract 3
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 abstract 1
- 125000006650 (C2-C4) alkynyl group Chemical group 0.000 abstract 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 abstract 1
- 239000005977 Ethylene Substances 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 abstract 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
El presente se refiere a procedimiento de preparación y usos. Reivindicación 1: Un compuesto de la fórmula (1), en donde: R1 es hidrógeno, halógeno, alquilo C1-4, cicloalquilo C3-7, cicloalquil(C3-7)-alquilo(C1-4), alcoxi C1-4, alcoxi(C1-4)- alquilo(C1-4), alcoxi(C1-4)-carbonilo, alquenilo C2-4, alquinilo C2-4, fluoroalquilo C1-4, fluoroalcoxi(C1-4)-alquilo(C1-4) o hidroxialquilo C1-4; R2 es hidrógeno, alquilo C1-4, cicloalquilo C3-7, cicloalquil(C3-7)-alquilo(C1-4), alcoxi(C1-4)- alquilo(C1-4), alquenilo C2-4, alquinilo C2-4, fluoroalquilo C1-4 o hidroxialquilo C1-4; R3 es hidrógeno, alquilo C1-4, cicloalquilo C3-7, cicloalquil(C3-7)-alquilo(C1-4), alcoxi(C1-4)-alquilo(C1-4), fluoroalquilo C1-4, fluoroalcoxi(C1-4)-alquilo(C1- 4), hidroxialquilo C1-4 o un radical arilalquilo C1-4, en donde arilo es un fenilo sustituido con R31 y R32, en donde R31 es hidrógeno, alquilo C1-4, fluoroalquilo C1-4, alcoxi C1-4 o fluoroalcoxi C1-4; y R32 es hidrógeno, alquilo C1-4, fluoroalquilo C1-4, alcoxi C1-4 o fluoroalcoxi C1-4; R4 es hidrógeno, alquilo C1-4, cicloalquilo C3-7, cicloalquil(C3-7)-alquilo(C1-4), alcoxi(C1-4)-alquilo(C1-4), fluoroalquilo C1-4, fluoroalcoxi(C1-4)-alquilo(C1-4) o hidroxialquilo C1-4; o en donde R3 y R4 juntos forman un radical metileno (-CH2-), etileno(-CH2-CH2-), propileno(-CH2-CH2-CH2-) o isopropilideno-(C(CH3)2-); R5 es hidrógeno, halógeno, alquilo C1-4 o fluoroalquilo C1-4; R6 es hidrógeno, halógeno, alquilo C1-4 o fluoroalquilo C1-4; y sus sales.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03028846 | 2003-12-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR046893A1 true AR046893A1 (es) | 2005-12-28 |
Family
ID=34684541
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040104662A AR046893A1 (es) | 2003-12-16 | 2004-12-15 | Bencimidazoles triciclicos |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20070037840A1 (es) |
| EP (1) | EP1697357A2 (es) |
| AR (1) | AR046893A1 (es) |
| AU (1) | AU2004298452A1 (es) |
| CA (1) | CA2549042A1 (es) |
| TW (1) | TW200524873A (es) |
| WO (1) | WO2005058893A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS20050730A (sr) * | 2003-04-04 | 2007-11-15 | Altana Pharma Ag., | Ciklični benzimidazoli |
| MX2012000275A (es) | 2009-07-09 | 2012-02-08 | Raqualia Pharma Inc | Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal. |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8300736D0 (sv) * | 1983-02-11 | 1983-02-11 | Haessle Ab | Novel pharmacologically active compounds |
| EP0401582B1 (de) * | 1989-06-01 | 1994-07-20 | BASF Aktiengesellschaft | Fünfring-heterocyclisch anellierte Chinolinderivate |
| SE9602286D0 (sv) * | 1996-06-10 | 1996-06-10 | Astra Ab | New compounds |
| WO1998042707A1 (en) * | 1997-03-24 | 1998-10-01 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Tetrahydropyrido compounds |
| AU3966600A (en) * | 1999-04-17 | 2000-11-02 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Haloalkoxy imidazonaphthyridines |
| NZ520837A (en) * | 2000-03-29 | 2005-01-28 | Altana Pharma Ag | Prodrugs of imidazopyridine derivatives |
| US6869949B2 (en) * | 2000-10-25 | 2005-03-22 | Altana Pharma Ag | Polysubstituted imidazopyridines as gastric secretion inhibitors |
-
2004
- 2004-12-15 AR ARP040104662A patent/AR046893A1/es unknown
- 2004-12-16 WO PCT/EP2004/053544 patent/WO2005058893A1/en not_active Ceased
- 2004-12-16 US US10/582,498 patent/US20070037840A1/en not_active Abandoned
- 2004-12-16 AU AU2004298452A patent/AU2004298452A1/en not_active Abandoned
- 2004-12-16 CA CA002549042A patent/CA2549042A1/en not_active Abandoned
- 2004-12-16 TW TW093139202A patent/TW200524873A/zh unknown
- 2004-12-16 EP EP04804890A patent/EP1697357A2/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP1697357A2 (en) | 2006-09-06 |
| CA2549042A1 (en) | 2005-06-30 |
| TW200524873A (en) | 2005-08-01 |
| WO2005058893A1 (en) | 2005-06-30 |
| WO2005058893A8 (en) | 2006-05-11 |
| AU2004298452A1 (en) | 2005-06-30 |
| US20070037840A1 (en) | 2007-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20151776A1 (es) | Compuestos de heteroarilo y sus usos | |
| PE20221010A1 (es) | Compuestos de imidazolil pirimidinilamina como inhibidores de cdk2 | |
| CY1114083T1 (el) | Συνδυασμος μιας ενωσης της 5-φαινυλοθειαζολης ως αναστολεας της κινασης pi3 με ενα αντιφλεγμονωδες, βρογχοδιασταλτικο ή αντιισταμινικο φαρμακo | |
| AR056764A1 (es) | Aminopirimidinas utiles como inhibidores de quinasa | |
| ES2567410T3 (es) | Nuevos sustratos de coelenterazina y métodos de uso | |
| PE20090042A1 (es) | Analogos de ciclopamina | |
| CY1114491T1 (el) | Παραγωγα βενζαζεπινης χρησιμα ως ανταγωνιστες της βαζοπρεσινης | |
| AR061380A1 (es) | 2-anilino-4(heterociclo) amino-pirimidinas | |
| CO6180440A2 (es) | Compuestos y composiciones como inhibidores de proteinquinasas | |
| ES2632567T3 (es) | Cetoenoles sustituidos con haloalquilmetilenoxi-fenilo | |
| AR067613A1 (es) | Inhibidores de adn-pk, uso y sintesis de los mismos | |
| CO6160229A2 (es) | Ciclopenta [d] pirimidinas como inhibidores de proteina quinasa akt | |
| PE20181304A1 (es) | Derivados de indol n-sustituidos como moduladores de los receptores de pge2 | |
| CO5580832A2 (es) | Compuestos isoquinolina terapeuticos | |
| AR078520A1 (es) | Compuesto heterociclico y su uso para el control de una plaga de artro-podos | |
| AR072016A1 (es) | Derivados de isoxazol que funcionan como potenciadores de los receptores de glutamato | |
| AR039554A1 (es) | Compuestos derivados de aminopirimidina y aminopiridina, su empleo, un metodo para su preparacion, composiciones que los comprenden, y compuestos intermediarios | |
| AR062366A1 (es) | Derivados de pirazoles como inhibidores no nucleosidicos de la transcriptasa inversa, composiciones farmaceuticas | |
| AR067058A1 (es) | Oxazolidinonas sustituidas y su uso para preparar medicamentos | |
| AR052312A1 (es) | 2- anilinopirimidinas sustituidas como inhibidores de la quinasa del ciclo celular o del receptor de la tirosina quinasa, su preparacion y medicamentos preparados en base al compuesto | |
| PE20160039A1 (es) | NUEVOS DERIVADOS DE PIRROLO[2,3-d]PIRIMIDINA | |
| UY32801A (es) | Nuevos derivados dihidroindolonas, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| AR061835A1 (es) | Derivados tetraciclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| AR039988A1 (es) | Derivados de benzoxazina como moduladores de 5-ht6 y usos de los mismos | |
| NO20055230L (no) | HIV-integraseinhibitorer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |